499 related articles for article (PubMed ID: 23563670)
41. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae.
Ella KM; Qi C; Dolan JW; Thompson RP; Meier KE
Arch Biochem Biophys; 1997 Apr; 340(1):101-10. PubMed ID: 9126282
[TBL] [Abstract][Full Text] [Related]
42. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites.
Duan RD; Cheng Y; Jönsson BA; Ohlsson L; Herbst A; Hellström-Westas L; Nilsson A
Pediatr Res; 2007 Jan; 61(1):61-6. PubMed ID: 17211142
[TBL] [Abstract][Full Text] [Related]
43. PPARalpha agonist induces the accumulation of ceramide in the heart of rats fed high-fat diet.
Baranowski M; Błachnio A; Zabielski P; Górski J
J Physiol Pharmacol; 2007 Mar; 58(1):57-72. PubMed ID: 17440226
[TBL] [Abstract][Full Text] [Related]
44. [Study of sphingomyelinase activity and sphingomyelin and ceramide levels in comparison with other lipid fractions of the cell nucleus in regenerating rat liver].
Pushkarev MIu; Borovkova OV; Alesenko AV
Biokhimiia; 1991 May; 56(5):903-12. PubMed ID: 1747416
[TBL] [Abstract][Full Text] [Related]
45. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
He X; Chen F; Gatt S; Schuchman EH
Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
[TBL] [Abstract][Full Text] [Related]
46. Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis.
Allan D
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):603-10. PubMed ID: 10642519
[TBL] [Abstract][Full Text] [Related]
47. Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke.
Altura BM; Gebrewold A; Zheng T; Altura BT
Brain Res Bull; 2002 Jul; 58(3):271-8. PubMed ID: 12128152
[TBL] [Abstract][Full Text] [Related]
48. Hyperthyroidism evokes myocardial ceramide accumulation.
Mikłosz A; Łukaszuk B; Chabowski A; Rogowski F; Kurek K; Żendzian-Piotrowska M
Cell Physiol Biochem; 2015; 35(2):755-66. PubMed ID: 25613909
[TBL] [Abstract][Full Text] [Related]
49. Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts.
Payne SG; Brindley DN; Guilbert LJ
J Cell Physiol; 1999 Aug; 180(2):263-70. PubMed ID: 10395296
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of neutrophil apoptosis via sphingolipid signaling in acute lung injury.
Lin WC; Lin CF; Chen CL; Chen CW; Lin YS
J Pharmacol Exp Ther; 2011 Oct; 339(1):45-53. PubMed ID: 21724966
[TBL] [Abstract][Full Text] [Related]
51. Sphingolipid metabolizing enzymes as novel therapeutic targets.
Billich A; Baumruker T
Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
[TBL] [Abstract][Full Text] [Related]
52. Anticancer compounds and sphingolipid metabolism in the colon.
Duan RD
In Vivo; 2005; 19(1):293-300. PubMed ID: 15796189
[TBL] [Abstract][Full Text] [Related]
53. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.
Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC
J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448
[TBL] [Abstract][Full Text] [Related]
54. Distinct effects of ceramide-generating pathways in prostate adenocarcinoma cells.
Condorelli F; Canonico PL; Sortino MA
Br J Pharmacol; 1999 May; 127(1):75-84. PubMed ID: 10369458
[TBL] [Abstract][Full Text] [Related]
55. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells.
Orsini M; Chateauvieux S; Rhim J; Gaigneaux A; Cheillan D; Christov C; Dicato M; Morceau F; Diederich M
Cell Death Differ; 2019 Sep; 26(9):1796-1812. PubMed ID: 30546074
[TBL] [Abstract][Full Text] [Related]
56. [The potential role for sphingolipids in neuropathogenesis of Alzheimer's disease].
Alesenko AV
Biomed Khim; 2013; 59(1):25-50. PubMed ID: 23650721
[TBL] [Abstract][Full Text] [Related]
57. Sphingolipids of transplantable rat nephroma-RA.
Kandyba AG; Somova OG; Kozlov AM; Zubova ES; Dudnik LB; Alessenko AV; Shvetz VI; Dyatlovitskaya EV
Biochemistry (Mosc); 2000 Jun; 65(6):703-6. PubMed ID: 10887290
[TBL] [Abstract][Full Text] [Related]
58. Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.
de Wit NM; Snkhchyan H; den Hoedt S; Wattimena D; de Vos R; Mulder MT; Walter J; Martinez-Martinez P; Hoozemans JJ; Rozemuller AJ; de Vries HE
J Alzheimers Dis; 2017; 60(3):795-807. PubMed ID: 27662305
[TBL] [Abstract][Full Text] [Related]
59. Sphingolipids in inflammatory hypoxia.
Glaser UG; Fandrey J
Biol Chem; 2018 Sep; 399(10):1169-1174. PubMed ID: 29908122
[TBL] [Abstract][Full Text] [Related]
60. Long-term food restriction prevents aging-associated sphingolipid turnover dysregulation in the brain.
Babenko NA; Shakhova EG
Arch Gerontol Geriatr; 2014; 58(3):420-6. PubMed ID: 24439723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
